Doxepin Rinse Significantly Reduces Mouth Pain for Head and Neck Cancer Patients Who Receive Radiation Therapy
October 29, 2012 11:10 ET | American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- When used as a rinse, doxepin, a tricyclic antidepressant, reduces oral mucositis (OM) in patients who receive radiation therapy (RT) for head and neck...
Memantine Delays Cognitive Decline in Brain Tumor Patients Who Receive Whole Brain Radiation Therapy
October 29, 2012 11:09 ET | American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Memantine, an N-Methyl-D-aspartate receptor antagonist typically prescribed to Alzheimer's patients, slows cognitive decline in brain cancer patients who...
Concurrent Use of Sorafenib and Stereotactic Body Radiotherapy for Advanced Liver Cancer Patients is Not Recommended Outside of Clinical Trials
October 28, 2012 15:41 ET | American Society for Radiation Oncology
BOSTON, Oct. 28, 2012 (GLOBE NEWSWIRE) -- Concurrent use of sorafenib and stereotactic body radiotherapy (SBRT) for advanced liver cancer patients resulted in high toxicity and is not recommended...
Prostate Cancer Patients Report Better Quality of Life in Early Follow-Up After Proton Beam Radiation Therapy Versus Two Other Common Modalities
October 28, 2012 15:38 ET | American Society for Radiation Oncology
BOSTON, Oct. 28, 2012 (GLOBE NEWSWIRE) -- Patients undergoing treatment for prostate cancer using proton beam therapy (PBT) reported a higher quality of life (QOL) in early follow-up with similar QOL...